title: Targeted DMS-MaPseq performed on HeLa cells with pladienolide B, reads mapped to MYC pre-mRNA
design: Triplicate DMS probing was performed on ~125,000 HeLa cells/well (24-well) treated for up to 2 hours with pladienolide B.